- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 90
StrideBio strikes series B deal
Novo co-led an $81.5m round for the gene therapy developer that included Sarepta Therapeutics, UCB Ventures, Takeda Ventures and Alexandria Venture Investments.
Mar 17, 2021StrideBio strikes $81.5m series B deal
UF Innovate Ventures has contributed to a series B round for StrideBio, partially based on research into gene therapies at University of Florida.
Mar 17, 2021Fenbeitong finds series C payment
Tencent co-led a $92.5m round for the corporate expense management tool provider, investing alongside new and returning backers including Eight Roads Ventures.
Mar 17, 2021Monte Rosa scales $95m series C
The money will fund the progress of the University of London-linked precision medicine developer's lead drug candidate into the clinic.
Mar 16, 2021Monte Rosa scales $95m series C
Alphabet subsidiary GV was part of a consortium in a round that will fund the progress of the precision medicine developer's lead drug candidate into the clinic.
Mar 16, 2021Skeleton Technologies powers up with $61m
The Harju Elekter-backed ultracapacitor producer will develop automated production technology with funding secured from the German government.
Mar 16, 2021Terminus turns to Alibaba in series A round
Alibaba Cloud's stake in the digitalisation technology provider now stands at over 31% following the latter's $61.5m series A round.
Mar 16, 2021Biocon buys a $40m piece of Bicara
The biopharmaceutical company has provided $40m in seed capital for the newly launched immuno-oncology drug developer.
Mar 16, 2021Genesis cracks series B code with $45m
GV and Salesforce Ventures joined existing investor Citi in a $45m round for the financial application development platform.
Mar 16, 2021Turtlemint takes $46m to close its series D
The insurance comparison platform developer has added Jungle Ventures funding to cash from investors including American Family and MassMutual.
Mar 15, 2021About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


